All companies
Phreesia logo

What smart money is saying about PhreesiaUnited States flag

PHR

No fund has written a full thesis on Phreesia in our archive, but 3 fund letters report a position in it, most recently Goodhart Partners Global Future Leaders Fund in September 2026.

Get an email when a fund buys, sells or pitches it

Summarize with Warren AI
3
Reported positions
0
Bought
1
Sold
3
Letters

Position history

Between Q1 2026 and Q3 2026, 3 fund letters reported a position in Phreesia, with 1 sell (trimmed or exited).

Fund letters reporting a position in Phreesia, by quarter
QuarterLettersBoughtSoldTheses
Q3 20261000
Q1 20262010

Bought and Sold count moves: the same sentence published by several funds of one house in a quarter counts once.

Fund activity · 3 positions · 1 move

  • “The conflict involving Iran unsettled markets and corporate confidence, and the US administration's drive to lower drug prices led large pharmaceutical companies to cut back on research and development, and on sales and marketing. That spending is revenue for several of our holdings, Doximity and Phreesia among them, and earnings disappointments followed.”
    Phreesia
  • “Orion S.A. (OEC) announced that its results continue to deteriorate which would result in significant leverage. We exited our investment after the announcement.  Remaining shares of Phreesia, Inc. (PHR) were sold following F3Q26 results where it became evident that the business model and growth rate were straying from our original thesis.”
    Phreesia
  • March 2026
    “AI disruption fears also contributed to the drawdown in Phreesia, which is a software provider with a key niche in the healthcare space. The company’s in-patient registration/check-in services and digital engagement platform are well-entrenched in hospital networks and specialty practices. Some of the pain in the stock was in response to a guide-down in advertising revenue, as customers such as vaccine providers and GLP-1 companies have scaled back their spending. With that said, Phreesia maintained their full-year EBITDA guidance, pointing to continued client growth and stronger pricing.”
    Phreesia

Read the letters behind these Phreesia positions

Every quote above comes from a fund letter in our archive. Get unlimited access to the letters themselves, and to Warren AI, which reads all of them for you.

View plans→
Share this ledger